This healthcare company - long on the books of its two BDC lenders - went on non-accrual in the IIQ 2025 for the first time. The potential damage is relatively modest.
This post is for paying subscribers only
You might also like...
Dec
27
Khoros, LLC: IIIQ 2025 Update
3 min read
Dec
24
National Dentex Labs: IIIQ 2025 Update
2 min read
Dec
23
Conair Holdings: IIIQ 2025 Update
2 min read
Dec
22
Kellermeyer Bergenson Services/ KBS Inc.: IIIQ 2025 Update